The document discusses methods of measuring and estimating glomerular filtration rate (GFR) to assess kidney function. It outlines two main methods - directly measuring GFR using exogenous or endogenous filtration markers in the blood or urine, and estimating GFR using equations like Cockcroft-Gault and MDRD study equation. While direct measurement is most accurate, estimated GFR using equations is sufficient for detecting, monitoring, and managing chronic kidney disease in most patients. Estimates are less accurate in populations without known chronic kidney disease.
Advancing dialysis multinational guidelines for increased time and frequency ...AdvancingDialysis.org
Clinical practice guidelines and appropriate indications from 5 medical societies in North America, Europe and Asia for increased hemodialysis frequency and time.
When to Initiate RRT in Patients with AKI - Does Timing Matter?Apollo Hospitals
Acute kidney injury is a serious illness which occurs commonly in the renal units and also in the ICU setting. It is an independent risk factor of increased mortality and morbidity, particularly when RRT is needed. The wide variation in utilization of RRT contributes to a lack of consensus among clinicians regarding the parameters which should guide the decision to initiate RRT.
When to Initiate RRT in Patients with AKI - Does Timing Matter?Apollo Hospitals
Acute kidney injury is a serious illness which occurs commonly in the renal units and also in the ICU setting. It is an independent risk factor of increased mortality and morbidity, particularly when RRT is needed. The wide variation in utilization of RRT contributes to a lack of consensus among clinicians regarding the parameters which should guide the decision to initiate RRT. This problem is confounded by a paucity of high quality evidence in the current literature. This review examines the role of usual biochemical parameters as well as conventional clinical indications for commencing RRT. It also discusses the potential role of biomarkers as predictors for the need of RRT in AKI. Initiating dialysis in AKI should be based on dynamic clinical criteria and not only on specific biochemical values.
Acute pancreatitis is a common medical problem. Initial phase of acute pancreatitis is characterized by inflammation. This is caused by release of cytokines and other pro inflammatory mediators. These further cause vasodilatation, intravascular volume depletion, and end organ hypoperfusion. The etiology can be varied but common causes are biliary (stone in CBD) and alcohol. Other causes are drugs, infections, trauma, idiopathic, post ERCP etc. Patients with severe pancreatitis have high risk of mortality (10%) which can go upto 30% if necrosis gets infected, which occurs in about 40% patients. Further, persistent organ failure increases the mortality up to 34–55% as compared to 0.3% with transient organ failure. Traditionally as per Atlanta classification, acute pancreatitis has been classified as mild or severe depending upon organ failure or local complications. Acute pancreatitis is a hyper-catabolic state. Moreover some of these patients may be malnourished to begin with (alcoholics). Thus their nutritional requirements are much more than ordinary person. There are good quality studies available to show that in absence of cholangitis, there is no benefit of doing early ERCP. Also, technically it is more difficult to do in such situations, and procedure related complication may be more. If in doubt, it may be worthwhile to do endoscopic ultrasound to document the presence of CBD stone before attempting to cannulate the CBD.
Antibiotic dose modification is crucial on patients with CRRT with sepsis and MOF. This talk highlights the importance of achieving plasma therapeutic drug concentration in ICU patients to enhance their chances of survival while on CRRT
This symposium provides an overview of the (r)evolution in intensive care medicine. The programme is based on lectures of 20 minutes where each speaker presents in two 10 minute talks (in der Beschränkung zeigt sich erst der Meister) the good things that happened in the last 40 years in critical care vs our mistakes or what is missing with respect to that topic. At the end of the session the speakers participate in an interactive round table discussion with online voting to get the audience involved. Will be discussed: Theoretical concepts, basic physiology and pathophysiology, monitoring, and future directions.
Advancing dialysis multinational guidelines for increased time and frequency ...AdvancingDialysis.org
Clinical practice guidelines and appropriate indications from 5 medical societies in North America, Europe and Asia for increased hemodialysis frequency and time.
When to Initiate RRT in Patients with AKI - Does Timing Matter?Apollo Hospitals
Acute kidney injury is a serious illness which occurs commonly in the renal units and also in the ICU setting. It is an independent risk factor of increased mortality and morbidity, particularly when RRT is needed. The wide variation in utilization of RRT contributes to a lack of consensus among clinicians regarding the parameters which should guide the decision to initiate RRT.
When to Initiate RRT in Patients with AKI - Does Timing Matter?Apollo Hospitals
Acute kidney injury is a serious illness which occurs commonly in the renal units and also in the ICU setting. It is an independent risk factor of increased mortality and morbidity, particularly when RRT is needed. The wide variation in utilization of RRT contributes to a lack of consensus among clinicians regarding the parameters which should guide the decision to initiate RRT. This problem is confounded by a paucity of high quality evidence in the current literature. This review examines the role of usual biochemical parameters as well as conventional clinical indications for commencing RRT. It also discusses the potential role of biomarkers as predictors for the need of RRT in AKI. Initiating dialysis in AKI should be based on dynamic clinical criteria and not only on specific biochemical values.
Acute pancreatitis is a common medical problem. Initial phase of acute pancreatitis is characterized by inflammation. This is caused by release of cytokines and other pro inflammatory mediators. These further cause vasodilatation, intravascular volume depletion, and end organ hypoperfusion. The etiology can be varied but common causes are biliary (stone in CBD) and alcohol. Other causes are drugs, infections, trauma, idiopathic, post ERCP etc. Patients with severe pancreatitis have high risk of mortality (10%) which can go upto 30% if necrosis gets infected, which occurs in about 40% patients. Further, persistent organ failure increases the mortality up to 34–55% as compared to 0.3% with transient organ failure. Traditionally as per Atlanta classification, acute pancreatitis has been classified as mild or severe depending upon organ failure or local complications. Acute pancreatitis is a hyper-catabolic state. Moreover some of these patients may be malnourished to begin with (alcoholics). Thus their nutritional requirements are much more than ordinary person. There are good quality studies available to show that in absence of cholangitis, there is no benefit of doing early ERCP. Also, technically it is more difficult to do in such situations, and procedure related complication may be more. If in doubt, it may be worthwhile to do endoscopic ultrasound to document the presence of CBD stone before attempting to cannulate the CBD.
Antibiotic dose modification is crucial on patients with CRRT with sepsis and MOF. This talk highlights the importance of achieving plasma therapeutic drug concentration in ICU patients to enhance their chances of survival while on CRRT
This symposium provides an overview of the (r)evolution in intensive care medicine. The programme is based on lectures of 20 minutes where each speaker presents in two 10 minute talks (in der Beschränkung zeigt sich erst der Meister) the good things that happened in the last 40 years in critical care vs our mistakes or what is missing with respect to that topic. At the end of the session the speakers participate in an interactive round table discussion with online voting to get the audience involved. Will be discussed: Theoretical concepts, basic physiology and pathophysiology, monitoring, and future directions.
A limited presentation about a) age related renal functional changes b) management of CKD, including advance care planning and transplantation referral c) management of potentially risky drugs in the elderly with CKD (NOACs)
Geriatric Nephrology (changes in renal physiology, Chronic Kidney Disease, Advanced Care Planning for the elderly patients with CKD, pharmacotherapy of common medical problems in the older individual with chronic kidney disease)
This slides contains 3 sections:
a. measurement of renal dysfuntion in cirrhosis
b. Evolution of hepatorenal syndrome
c. treatment of hepatorenal Syndrome
In this slide i outlined an open source article, how already 12 years have elapsed over it's publication. I thought it is interesting and i am also sharing it's fulltext link: https://diabetes.diabetesjournals.org/content/56/6/1718
2. Review article
The new england journal of medicine
Assessing Kidney Function-
Measured and Estimated
Glomerular Filtration Rate
Lesley A. Stevens, M.D., Josef Coresh, M.D., Ph.D., Tom Greene, Ph.D.,
and Andrew S. Levey, M.D.
3. the strengths and weaknesses
of current methods of measuring
and estimating GFR as applied to
chronic kidney disease.
4. Chronic Kidney Disease
A persistent reduction in the GFR to less than 60
ml per minute per 1.73m2of body-surface area
or
the presence of kidney damage, regardless of
the cause, for three or more months.
Risk factors:
an age of more than 60 years, hypertension,
diabetes, cardiovascular disease, and a family
history of the disease.
5. Measurement of GFR with
Filtration Markers
(urinary or plasma clearance)
• Exogenous: inulin,iothalamate,EDTA, and
iohexol.
• Endogenous: Creatinine, Cystatin C
7. ENDOGENOUS MARKERS:
Creatinine
• Urinary clearance:
timed urine collection
• blood sampling during
the collection period
• Creatinine clearance
has reciprocal
relationship with the
serum creatinine level.
• Drugs, trimethoprim &
cimetidine clearance
and serum level
• the relationship
between the levels of
serum creatinine and
GFR varies among
persons & over time.
8.
9. Cystatin C
• Reabsorbed and catabolized by the tubular
epithelial cells; only small amounts are
excreted in the urine so its urinary clearance
cannot be measured.
• The generation of cystatin C appears to be less
variable from person to person than that of
creatinine.
• However, serum levels are Influenced by
corticosteroid use and related to age, sex,
weight, height, smoking status, and the level of
C-reactive protein.
10. Estimation of GFR with Equations
Two creatinine-based equations
• The Cockcroft–Gault equation i.e
Ccr = [(140 − age) × weight]/(72 × Scr ) × 0.85 (if the subject is female)
• The Modification of Diet in Renal Disease
(MDRD) study equation i.e
GFR = 186 × (Scr)−1.154 × (age)−0.203 × 0.742 (if the subject is female)
or × 1.212 (if the subject is black).
It estimates GFR adjusted for body-surface area. It was found to be
more accurate.
11. Evaluation of Current Estimating Equations
• In some studies the MDRD study equation has
been reported to be more accurate than the
Cockcroft–Gault equation but not in other.
• The Cockcroft–Gault equation appears to be less
accurate than the MDRD study equation in older
and obese people
• The MDRD study equation is reasonably accurate
in nonhospitalized patients known to have chronic
kidney disease
• Both the MDRD study and the Cockcroft–Gault
equations have been reported to be less accurate
in populations without chronic kidney disease.
12.
13. Use of GFR Estimates
• Detection of Chronic Kidney Disease
• Monitoring Progression of Chronic Kidney
Disease
• Evaluation and Management of Complications
• GFR and Referral to Nephrologists
• Medications and Chronic Kidney Disease
• Assessment of Risk for Cardiovascular Disease
14.
15. When to Consider Clearance Measurements Instead
of Estimated GFR
When more accurate estimates
may be necessary
• to evaluate people for kidney donation,
• to administer drugs (e.g.methotrexate), or
• for research protocols.
Clearance of exogenous filtration markers provides
the most accurate measure of GFR
16. GFR Reporting by Clinical Laboratories
• Laboratories should report a specific value
of GFR only if the estimated GFR is less than
60 ml per minute per 1.73 m2
• Higher values should be reported as “GFR is
60 ml per minute per 1.73 m2 or more.
17. Conclusions
• The main limitation of current GFR estimates is
the greater inaccuracy in populations without
known chronic kidney disease than in those with
the disease.
• However current GFR estimates
facilitate detection, evaluation, and management
of the disease.